Skip to content
Adam Torkildson – Lifestyle
Author:
Renew Biotechnologies
Renew Biotechnologies Enters Collaboration to Evaluate NeuroLens® in Multiple Sclerosis and Related Neuroimmunologic Diseases
October 1, 2026
Renew Biotechnologies Publishes Peer-Reviewed Research Advancing Cell-Type-Associated Biomarkers of Neurodegeneration
August 7, 2026
Renew Labs Receives Accreditation from the College of American Pathologists
July 14, 2026
Renew Biotechnologies Unifies Wasatch BioLabs and Resonant Under One Brand to Advance Sequencing-Based Diagnostics
July 9, 2026